Market News (Page 159) - TendieTensor

Market News Page 159 of 293 • 7,310 articles

Faraday Future Founder and Co-CEO YT Jia Shares Weekly Investor Update: FF Completes its “Dual Flywheel, Dual Bridge, and Dual Listed-Company” Structure; First batch of FX Super One Complete Sets of Components to Arrive at Port of Long Beach Next Week

GlobeNewswire Inc. • Yt Jia

Faraday Future Founder and Co-CEO YT Jia Shares Weekly Investor Update: FF Completes its “Dual Flywheel, Dual Bridge, and Dual Listed-Company” Structure; First batch of FX Super One Complete Sets of Components to Arrive at Port of Long Beach Next Week

11/23/2025 07:34 PM • Faraday Future completed its 'Dual Flywheel, Dual Bridge, and Dual Listed-Company' structure, becoming the majority stockholder of AIxCrypto. The first batch of FX Super One components will arrive at the Port of Long Beach, with vehicles to be showcased at the LA Auto Show.

FFAI - Company is expanding its corporate structure, preparing for vehicle production, and showcasing new models at an auto show

#electric vehicles #EV #AIxCrypto #dual-listed #FX Super One

What to Know Before Buying Celsius Stock

The Motley Fool • Neil Patel

What to Know Before Buying Celsius Stock

11/23/2025 10:35 AM • Celsius, a health-focused energy drink company, experienced remarkable 7,330% stock growth before declining 58% from its peak. Despite strong revenue growth and potential international expansion, the company faces challenges with inventory buildup and limited brand recognition compared to market leaders.

ORCL - Listed as a neocloud provider without specific performance details
CELH - Mixed performance with strong revenue growth (173% YoY) but slower scanner sales, potential international expansion, and risks of brand irrelevance

#energy drinks #stock performance #revenue growth #market expansion

Coinbase, Micron, And XPeng Are Among Top 10 Large Cap Losers Last Week (Nov. 17-Nov. 21): Are the Others in Your Portfolio?

Benzinga • Nabaparna Bhattacharya

Coinbase, Micron, And XPeng Are Among Top 10 Large Cap Losers Last Week (Nov. 17-Nov. 21): Are the Others in Your Portfolio?

11/23/2025 09:30 AM • Multiple large-cap stocks experienced significant declines last week, with companies in tech, semiconductor, and cryptocurrency sectors seeing notable losses due to missed earnings, analyst downgrades, and market reversals.

CRWV - Mentioned as a neocloud provider without specific details about recent performance
ACM - Lost 21.92% after fourth-quarter sales missed expectations and analysts lowered price forecasts

#large cap stocks #market performance #earnings #stock decline

SNPS COURT ALERT: Synopsys, Inc. Investors that Lost Money May have been Affected by Fraud -- Contact BFA Law by December 30

GlobeNewswire Inc. • Bleichmar Fonti & Auld Llp

SNPS COURT ALERT: Synopsys, Inc. Investors that Lost Money May have been Affected by Fraud -- Contact BFA Law by December 30

11/23/2025 07:41 AM • Synopsys faces a class action lawsuit alleging securities fraud after revealing significant challenges in its Design IP segment, leading to a 36% stock price drop in September 2025.

PFE - Briefly mentioned in a related headline without substantive discussion in the article
SNPS - The company experienced a substantial stock price decline of 36% after disclosing underperformance in its Design IP business, with revenue dropping 7.7% year-over-year and net income declining 43%. The lawsuit alleges the company misrepresented its business model and customer relationships.

#securities fraud #class action #Design IP #stock decline #investor lawsuit

MLTX COURT ALERT: MoonLake Immunotherapeutics Investors that Lost Money May have been Affected by Fraud -- Contact BFA Law by December 15

GlobeNewswire Inc. • Bleichmar Fonti & Auld Llp

MLTX COURT ALERT: MoonLake Immunotherapeutics Investors that Lost Money May have been Affected by Fraud -- Contact BFA Law by December 15

11/23/2025 07:38 AM • MoonLake Immunotherapeutics faces a securities fraud lawsuit after reporting disappointing Phase 3 VELA trial results for its investigational drug sonelokimab, causing its stock price to drop nearly 90%.

MLTX - Stock price collapsed by 90% after failed clinical trials, potential misrepresentation of clinical data, and lawsuit alleging securities fraud

#securities fraud #biotechnology #clinical trials #hidradenitis suppurativa #nanobody

LRN COURT ALERT: Stride, Inc. Investors that Lost Money May have been Affected by Fraud -- Contact BFA Law by January 12

GlobeNewswire Inc. • Bleichmar Fonti & Auld Llp

LRN COURT ALERT: Stride, Inc. Investors that Lost Money May have been Affected by Fraud -- Contact BFA Law by January 12

11/23/2025 07:36 AM • Stride, an education technology company, is facing a class action lawsuit alleging securities fraud by inflating enrollment numbers, ignoring compliance requirements, and misrepresenting business performance, which led to significant stock price drops.

KVUE - Stock climbed over 12% after acquisition, indicating market sees potential in the deal